VISTAGEN THERAPEUTICS, INC. Preferred Stock, Value, Issued
VISTAGEN THERAPEUTICS, INC. (VTGN) had Preferred Stock, Value, Issued of $0 as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:PreferredStockValue · last filed 2026-08-14
- 2026-06-30: Preferred Stock, Value, Issued $0.00.
- 2026-03-31: Preferred Stock, Value, Issued $0.00.
- 2025-12-31: Preferred Stock, Value, Issued $0.00.
- 2025-09-30: Preferred Stock, Value, Issued $0.00.
| Period end | Preferred Stock, Value, Issued | Preferred Stock, Value, Issued as first filed |
|---|---|---|
| 2026-06-30 | $0.00 10-Q · filed 2026-08-14 | |
| 2026-03-31 | $0.00 10-Q · filed 2026-08-14 | |
| 2025-12-31 | $0.00 10-Q · filed 2026-02-12 | |
| 2025-09-30 | $0.00 10-Q · filed 2025-11-13 | |
| 2025-06-30 | $0.00 10-Q · filed 2025-08-07 | |
| 2025-03-31 | $0.00 10-K · filed 2026-06-15 | |
| 2024-12-31 | $0.00 10-Q · filed 2025-02-13 | |
| 2024-09-30 | $0.00 10-Q · filed 2024-11-07 | |
| 2024-06-30 | $0.00 10-Q · filed 2024-08-13 | |
| 2024-03-31 | $0.00 10-K · filed 2025-06-17 | |
| 2023-12-31 | $0.00 10-Q · filed 2024-02-13 | |
| 2023-09-30 | $0.00 10-Q · filed 2023-11-09 | |
| 2023-06-30 | $0.00 10-Q · filed 2023-08-10 | |
| 2023-03-31 | $0.00 10-K · filed 2024-06-11 | |
| 2022-12-31 | $0.00 10-Q · filed 2023-02-07 | |
| 2022-09-30 | $0.00 10-Q · filed 2022-11-10 | |
| 2022-06-30 | $0.00 10-Q · filed 2022-08-11 | |
| 2022-03-31 | $0.00 10-K · filed 2023-06-28 | |
| 2015-06-30 | $500.00 10-Q · filed 2015-08-14 | |
| 2015-03-31 | $500.00 10-Q · filed 2015-08-14 | |
| 2014-12-31 | $500.00 10-Q · filed 2015-02-17 | |
| 2014-09-30 | $500.00 10-Q · filed 2014-11-19 | |
| 2014-06-30 | $500.00 10-Q · filed 2014-08-12 | |
| 2014-03-31 | $500.00 10-K · filed 2015-06-29 | |
| 2013-12-31 | $500.00 10-Q · filed 2014-02-14 | |
| 2013-09-30 | $500.00 10-Q · filed 2013-11-14 | |
| 2013-06-30 | $500.00 10-Q · filed 2013-08-14 | |
| 2013-03-31 | $500.00 10-Q · filed 2014-11-19 | |
| 2012-12-31 | $500.00 10-Q · filed 2013-02-14 | |
| 2012-09-30 | $500.00 10-Q · filed 2012-11-14 | |
| 2012-03-31 | $500.00 10-Q · filed 2013-11-14 | $400.00 10-Q · filed 2012-11-14 |
| 2011-12-31 | $0.00 10-Q · filed 2012-02-14 | |
| 2011-09-30 | $0.00 10-Q · filed 2011-11-14 | |
| 2011-03-31 | $14.53M 10-K · filed 2012-07-02 | $14.53M 10-Q · filed 2011-08-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B |